MarketsStocksSUVEN
SU

Suven Life Sciences Ltd

NSE: SUVENBSE: 530239Healthcare
Download Research Report7-page PDF
233.00
-1.83%
NSE · auto-updates while market open
Prev Close
₹221.19
Day High
₹245.95
Day Low
₹230.60
Mkt Cap
₹6,132 Cr
P / E
-
P / B
10.4
ROE
-78.8%
52W High
₹299.99
52W Low
₹124.11
Key Metrics
Market Cap
₹6,132 Cr
P / E
-
P / B
10.36
EV / EBITDA
-
ROCE
-78.8%
ROE
-78.8%
Debt / Equity
0.00
Book Value
₹22.43
EPS
-
Div Yield
0.0%
Face Value
₹1
Promoter Holding
70.2%
Revenue · ₹ Cr
14
FY20
13
FY21
12
FY22
14
FY23
12
FY24
7
FY25
7
FY26
Net Profit · ₹ Cr
-94
-72
-122
-118
-105
-161
-276
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹7.5
₹6.8
₹-2.0
₹-5.7
₹-9.6
₹-6.6
₹-4.8
FY16FY19FY20FY21FY22FY23FY24
P / E Ratio · price ÷ TTM EPS
2-60-13Jun 21Feb 23Oct 24Jun 26
TTM EPS
Q1 2026 snapshot
Sales
₹8 Cr
Operating profit
-
OPM
-
Net profit
₹-46 Cr
EPS
₹-2.02
Scorecard · 7 axes
Quality
Weak
33/100
Valuation
-
Growth
Bad
-29.4%
Profitability
Bad
-78.8%
Performance
Weak
+1.6%
Entry Point
Good
78%
Red Flags
Strong
0 flags
Shareholding Pattern
70.2%Promoter
Promoter70.2%
FII0.9%
DII4.6%
Public24.3%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1.612.692.474.75.588.3
Net Profit-39.117-43.945-51.517-77.31-101.922-45.596
NPM %-2429.8%-1633.6%-2085.7%-1644.9%-1826.6%-549.3%
AlertPre-trade